WAUKESHA, Wis., April 14, 2014 /PRNewswire/ -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced U.S. FDA 510(k) clearance of its Revolution* CT^, which will enable physicians to diagnose even the most challenging patients. This innovative technology provides uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution and temporal resolution – all in one CT scanner.